Αρχική World News FDA Approves Ensartinib for ALK-positive Locally Advanced or Metastatic Non-Small Cell Lung... World News FDA Approves Ensartinib for ALK-positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer Από Ogkologos - 6 Φεβρουαρίου, 2025 695 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the eXALT3 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Dealing With Fears 24 Μαρτίου, 2021 How to Talk About Cancer With Someone Who Has It 24 Αυγούστου, 2021 Get the Most out of Seasonal Fruits! 28 Δεκεμβρίου, 2020 Women in Science: Celebrating with our Women of Influence initiative 15 Μαρτίου, 2023 Φόρτωση περισσοτέρων HOT NEWS How Your Oncology Nurse Can Help You During Cancer Atezolizumab Plus Bevacizumab Approved to Treat Liver Cancer Tips from Your Cancer Care Team – Coping with Treatment During... Political Interests Are A Major Adversary in the War on Women